로딩 중…
지수 로딩 중…
Janux Therapeutics, Inc.
JANX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$14.22+0.49%
2026-06-18
Price Chart
Janux Therapeutics, Inc.-37.41%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $867M |
| Revenue | $22M |
| Net Income | $-114M |
| Total Assets | $1.03B |
| Net Assets | $942M |
| Value | |
| P/B | 0.92x |
| P/S | 40.12x |
| FCF Yield | -9.05% |
| Profitability | |
| ROE | -12.16% |
| ROA | -11.13% |
| Op. Margin | -726.34% |
| Revenue Growth | -5.55% |
| Financial Health | |
| Debt Ratio | 9.21% |
| Total Debt | $22M |
| FCF | $-78M |
| Cash | $52M |
| Current Ratio | 17.01x |
| Performance | |
| 1Y Return | -37.41% |
| 1M Return | 2.97% |
| From 52W High | -59.76% |
| 1Y MDD | -64.94% |
| Trading | |
| Volume | 1,034,109 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $-1.83 |
| BPS | $15.44 |